Clearly, further studies are warranted to explore the rolesof PPAR-δ in cardiovascularpathophysiology and to exploit this lipid-sensing receptor as a therapeutictarget for metabolic syndrome and its cardiovascularcomplications. This evidence concerns the gene PPARD and metabolic syndrome.